Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
HCC1395 | Ceritinib | ALK | RTK | 1.6025 | -0.6268 | 0.2363 | 0.0809 | 1.8434 | 2.6534 | 0.99554 |
HCC1395 | Neratinib | EGFR/HER2 | RTK | 0.95453 | 0.0167 | 0.1503 | 0.0198 | 0.8768 | 3.3415 | 0.98547 |
HCC1395 | Tivantinib | MET | RTK | 0.47525 | -0.4835 | 0.4006 | 0.1208 | 1.5047 | 0.75467 | 0.99624 |
HCC1395 | Cediranib | VEGFR/cKIT | RTK | 1.571 | -0.4825 | 0.2460 | 0.0671 | 1.0270 | 4.579 | 0.97022 |
HCC1395 | Cabozantinib | VEGFR2/MET | RTK | 5.5518 | 0.1138 | 0.0722 | 0.0131 | 1.6522 | 9.2961 | 0.98977 |
HCC1419 | Abemaciclib | CDK4/6 | Cell cycle | 0.10375 | 0.2278 | 0.4350 | -0.0030 | 0.6549 | 0.0234 | 0.9117 |
HCC1419 | Palbociclib | CDK4/6 | Cell cycle | 0.48725 | 0.4414 | 0.2239 | -0.0054 | 1.2398 | 0.053717 | 0.97241 |
HCC1419 | AZD7762 | CHK1/2 | Cell cycle | 0.068618 | -0.0826 | 0.5614 | 0.1156 | 2.0553 | 0.072481 | 0.98917 |
HCC1419 | Volasertib | PLK | Cell cycle | 0.020718 | 0.0685 | 0.3636 | 0.0462 | 1.8241 | 0.018178 | 0.98538 |
HCC1419 | Dinaciclib | pan CDK | Cell cycle | 0.026695 | -0.4761 | 0.5131 | 0.1238 | 5.0000 | 0.030191 | 0.99589 |
HCC1419 | Cisplatin | Chemo | Chemotherapy | 1.7988 | 0.0949 | 0.2293 | 0.0086 | 1.0769 | 2.0814 | 0.93793 |
HCC1419 | Doxorubicin | Chemo | Chemotherapy | 0.025082 | -0.4663 | 0.5904 | 0.0473 | 0.5199 | 0.10425 | 0.94593 |
HCC1419 | Taxol | Chemo | Chemotherapy | 0.0052608 | 0.2143 | 0.4700 | 0.0981 | 2.1841 | 0.0040283 | 0.97754 |
HCC1419 | Topotecan | Topo I | Chemotherapy | 0.0071886 | -0.7857 | 0.9904 | 0.1711 | 0.4002 | 0.11192 | 0.94532 |
HCC1419 | Etoposide | Topo II | Chemotherapy | 0.73579 | 0.0317 | 0.3201 | 0.0034 | 1.8770 | 0.70309 | 0.96133 |
HCC1419 | Dasatinib | BCR/ABL | MAPK/nRTK | 0.82399 | -0.1962 | 0.3189 | 0.0194 | 0.7548 | 2.3816 | 0.99358 |
HCC1419 | Trametinib | MEK | MAPK/nRTK | 0.031029 | 0.4259 | 0.2875 | -0.0031 | 1.4893 | 0.0089457 | 0.98063 |
HCC1419 | Saracatinib | SRC | MAPK/nRTK | 0.91888 | -0.1146 | 0.2758 | 0.0128 | 0.8021 | 1.8388 | 0.98394 |
HCC1419 | ABT-737 | Bcl2/XL | Misc | 9.84 | 0.4715 | 0.0022 | 0.0163 | 5.0000 | 11.4973 | 0.95757 |
HCC1419 | Vorinostat | HDAC | Misc | 1.735 | -0.2557 | 0.1917 | 0.0407 | 2.1116 | 2.1704 | 0.99173 |
HCC1419 | Luminespib | HSP90 | Misc | 0.0069643 | -0.2968 | 0.6506 | 0.1579 | 2.0439 | 0.0087353 | 0.99699 |
HCC1419 | A-1210477 | Mcl-1 | Misc | 14.536 | 0.7081 | 0.0402 | 0.0018 | 1.8053 | 26.3399 | 0.8672 |
HCC1419 | Olaparib | PARP | Misc | Inf | 0.6322 | 0.0273 | -0.0012 | 2.1535 | 5.2752 | 0.95353 |
HCC1419 | Bleomycin | Radiation | Misc | 4.4662 | 0.3545 | 0.1588 | -0.0001 | 0.8100 | 4.0786 | 0.85928 |
HCC1419 | Ipatasertib | AKT | PI3K/mTOR | Inf | 0.5051 | 0.1071 | 0.0007 | 1.4251 | 0.82031 | 0.95841 |